ACWX - iShares MSCI ACWI ex U.S. ETF
| Previous Close | 49.90 |
| Open | 49.71 |
| Bid | 49.81 x 1000 |
| Ask | 49.82 x 2200 |
| Day's Range | 49.51 - 49.83 |
| 52 Week Range | 44.44 - 53.74 |
| Volume | 216,973 |
| Avg. Volume | 683,520 |
| Net Assets | 3.15B |
| NAV | 49.37 |
| PE Ratio (TTM) | N/A |
| Yield | 2.43% |
| YTD Return | -0.52% |
| Beta (3y) | 1.00 |
| Expense Ratio (net) | 0.32% |
| Inception Date | 2008-03-26 |
- Zacks•23 days ago
Dividend & International: 2 ETFs to Watch on Outsized Volume
DHS and ACWX saw massive trading volumes on Friday session.
- Zacks•last month
Davis Advisors Launches International Equity ETF
Davis Advisors rolls out International Equity ETF.
- MarketWatch•last month
U.S. dollar set to face more pain in 2018, so here’s how to prepare, says Wells Fargo
A Wells Fargo strategist in a Tuesday research note make the case that it may be time to give up the ghost, with more pain for dollar bulls in the offing, even if the bank doesn’t think that the buck will ...
- ETF.com•7 months ago
Beware: Portfolio Risk Has Dropped
Even though risk levels are at historic lows, that doesn’t mean they’ll remain there.
- Forbes•8 months ago
The Four Seasons Of Trump: Two Secular Trades For The Post-American Century
The curious metamorphoses of D. Trump: dangerous populist, a new Reagan, an eccentric Republican, and a harmless fool What the Trump rally means The dawn of a new era for international investing
- Zacks•10 months ago
IMF Lowers U.S. Growth Outlook: International ETFs to Buy
IMF lowers U.S. growth outlook to 2.1% for this year and for 2018.
- Market Realist•11 months ago
GlaxoSmithKline’s Segment Performances in 1Q17
GlaxoSmithKline (GSK) reported a 19.0% rise in 1Q17 revenues to ~7.4 billion pounds, driven by an operational rise of 5.0% and a favorable currency impact of 14.0%.
